Results 321 to 330 of about 114,065 (338)

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

Lancet, The, 2007
Daniel Catovsky
exaly  

Lymphocytic Leukaemias, Acute and Chronic

Clinics in Haematology, 1980
J, Whang-Peng, T, Knutsen
openaire   +2 more sources

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

The Lancet Haematology, 2017
Jeffrey A Jones, T. Robak, Jennifer R. Brown, F. Awan, X. Badoux, S. Coutre, J. Loscertales, K. Taylor, E. Vandenberghe, M. Wach, N. Wagner-Johnston, L. Ysebaert, L. Dreiling, R. Dubowy, G. Xing, I. Flinn, C. Owen   +16 more
semanticscholar   +1 more source

From pathogenesis to treatment of chronic lymphocytic leukaemia

Nature Reviews Cancer, 2009
Thorsten Zenz, Daniel Mertens, Ralf Küppers   +2 more
exaly  

Chronic Myelocytic Leukemia Developing as a Second Cancer in a Patient with Chronic Lymphocytic Leukemia

Ca-A Cancer Journal for Clinicians, 1981
exaly  

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

Lancet, The, 2004
Peter W Thomas, Louis M Staudt
exaly  

Chronic Lymphocytic Leukemia

Ca-A Cancer Journal for Clinicians, 1989
exaly  

Chemoimmunotherapy of chronic lymphocytic leukemia

Nature Reviews Clinical Oncology, 2010
Constantine S Tam
exaly  

Prognosis in Chronic Lymphocytic Leukemia

Ca-A Cancer Journal for Clinicians, 1961
exaly  

Chronic myelogenous leukaemia and chronic lymphocytic leukaemia

Oncology Times, 2004
openaire   +1 more source